Genelux (GNLX) FCF Margin (2022 - 2024)
Genelux (GNLX) posted quarterly FCF Margin of 54800.0% for Q1 2024, down 5203588.0% year-over-year from N/an in Q2 2023, and down 1882.55% quarter-over-quarter from 2764.12% in Q1 2023.
Genelux (GNLX) FCF Margin (2022 - 2024) Analysis & Trends
Genelux's FCF Margin history runs 3 years deep, the most recent figure standing at 54800.0% for Q1 2024.
- In Q1 2024, FCF Margin fell 5203588.0% year-over-year to 54800.0%; the TTM figure through Dec 2024 stood at 270112.5% (down 25758309.0% YoY), while the FY2025 annual figure was 329575.0%, down 5946250.0% from the prior year.
- FCF Margin for Q1 2024 stood at 54800.0%, down from 2764.12% in the prior quarter.
- The five-year high for FCF Margin was 14.02% in Q4 2022, with the low at 54800.0% in Q1 2024.
- The 3-year median for FCF Margin is 2764.12% (2023), against an average of 19183.37%.
- Peak annual rise in FCF Margin reached 5203588 bps in 2024, while the deepest fall reached 5203588 bps in 2024.
- Genelux's FCF Margin stood at 14.02% in 2022, then sank by 19820 bps to 2764.12% in 2023, then tumbled by 1883 bps to 54800.0% in 2024.
- Business Quant data shows GNLX's FCF Margin at 54800.0% in Q1 2024, 2764.12% in Q1 2023, and 14.02% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 70.82% |
| 10 | Genelux | 120.09 Mn | 120.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -54,800.00% |
| Mar 31, 2023 | -2,764.12% |
| Dec 31, 2022 | 14.02% |